Back to top
Top
U.S. flag

An official website of the United States government

Antidepressant Medication Management

eCQM Compare View

Compare Versions of: "Antidepressant Medication Management"

The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.

Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.

Compare 2026 version to

Table Options
Measure Information 2026 Performance Period
Title Antidepressant Medication Management
CMS eCQM ID CMS128v14
CBE ID* Not Applicable
MIPS Quality ID 009
Measure Steward National Committee for Quality Assurance
Description

Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates are reported. a. Percentage of patients who remained on an antidepressant...

Show more >
Measure Scoring Proportion measure
Measure Type Process
Stratification

None

Risk Adjustment

None

Rationale

Depression affects over 17 million adults in the U.S. (NIMH, 2021) and is estimated to affect nearly a quarter of adults in their lifetime (Burcusa & Iacono, 2007). Symptoms of depression include disturbances in appetite and sleep, anxiety, decreased concentration, and suicidal ideation...

Show more >
Clinical Recommendation Statement

American Psychological Association (2019): - "For initial treatment of adult patients with depression, the panel recommends the following in the context of sharing decision-making with the patient when considering options:

1. That clinicians offer either psychotherapy or second-generation...

Show more >
Improvement Notation

Higher score indicates better quality

Definition

Intake Period: The 12-month window starting on May 1 of the year prior to the measurement period and ending on April 30 of the measurement period.

Index Prescription Start Date (IPSD): The date of the earliest prescription dispensing event for an antidepressant medication during the...

Show more >
Guidance

To identify new treatment episodes for major depression, there must be a 105-day negative medication history (a period during which the patient was not taking antidepressant medication) prior to the dispensing event associated with the IPSD.

This eCQM is a patient-based measure.

 

This...

Show more >
Initial Population

Patients 18 years of age and older as of the IPSD who were dispensed antidepressant medications during the Intake Period, and were diagnosed with major depression 60 days prior to, or 60 days after the dispensing event and had a visit 60 days prior to, or 60 days after the dispensing...

Show more >
Denominator

Equals Initial Population

Denominator Exclusions

Exclude patients who are in hospice care for any part of the measurement period.

Patients who were actively on an antidepressant medication in the 105 days prior to the IPSD.

Numerator

Numerator 1: Patients who have received antidepressant medication for at least 84 days (12 weeks) of continuous treatment beginning on the IPSD through 114 days after the IPSD (115 total days).

Numerator 2: Patients who have received antidepressant medications for at least 180 days (6...

Show more >
Numerator Exclusions

None

Denominator Exceptions

None

Telehealth Eligible Yes
Next Version No Version Available
Previous Version
Last Updated: May 07, 2025